Who
Bradley Evan Burnam
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Turn Therapeutics.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Apr 2026
- Last trade
- 28 May 2026
- Last filed
- 1 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 May 2026filed 1 Jun 2026 | TTRX Turn TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TTRX Turn TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TTRX Turn TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TTRX Turn TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TTRX Turn TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TTRX Turn TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TTRX Turn TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TTRX Turn TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 2 Apr 2026filed 3 Apr 2026 | TTRX Turn TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | TTRX Turn Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.